QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

IMTX

QT50Immatics N.V.
NASDAQ·Healthcare·Biotechnology·Germany
Latest market price
9.78
+0.26+2.73%
OverviewShort InterestFilings
IMTXQT50Immatics N.V.·NASDAQ
OverviewShort InterestFilings
9.78+2.73%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-1.98
Insider Own-
Shs Outstand136.67M
Perf Week7.95%
Market Cap1.28BForward P/E-EPS next Y-1.93Insider Trans-Shs Float-Perf Month-8.60%
Enterprise Value948.76MPEG0.05EPS next Q-0.56Inst Own-Short Float-Perf Quarter0.72%
Income-244865187.00P/S29.87EPS this Y0.57%Inst Trans-Short Ratio-Perf Half Y-3.07%
Sales42.77MP/B2.45EPS next Y2.00%ROA-39.42%Short Interest-Perf YTD-6.86%
Book/sh3.86P/C-EPS next 5Y-ROE-45.27%52W High12.41 -21.19%Perf Year59.28%
Cash/sh3.84P/FCF-EPS past 3/5Y-ROIC-42.89%52W Low5.05 93.66%Perf 3Y-
Dividend Est.-EV/EBITDA-4.09Sales past 3/5Y-33.30% 8.45%Gross Margin100.00%Volatility3.16% 3.81%Perf 5Y-
Dividend TTM-EV/Sales22.18EPS Y/Y TTM-1413.83%Oper. Margin-570.30%ATR (14)0.55Perf 10Y-
Dividend Ex-Date-Quick Ratio8.78Sales Y/Y TTM-74.56%Profit Margin-574.86%RSI (14)45.80Recom2.00
Dividend Gr. 3/5Y-Current Ratio8.78EPS Q/Q-42.86%SMA20-3.69%Beta1.58Target Price25.00
Payout0.00%Debt/Eq0.03Sales Q/Q-55.00%SMA50-8.69%Rel Volume0.87Prev Close9.52
Employees554LT Debt/Eq0.03EarningsAug 12SMA200-0.24%Avg Volume476.13KPrice9.78
IPO DateDec 12, 2018Option/ShortYes / YesEPS/Sales Surpr.-19.05% -10.00%Net Debt/EBITDA1.42Volume414,323Change2.73%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-19-26ReiteratedMizuho Securities$23 → $25
Dec-04-25ReiteratedLeerink Partners$17
Oct-29-25ReiteratedMizuho Securities$16 → $19
Sep-17-25InitiatedGuggenheimBuy$16
May-16-24ReiteratedMizuho Securities$14 → $16
Latest News
Jun-16-26
Jun-16-2602:19AM
Immatics: PRAME Is Becoming More Than A Single-Asset StorySeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue4354169
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A000
Gross Profit4354169
Selling, General and Administrative Excl. Other625850
Research and Development233207160
Other Operating Expense-5-50
Operating Income-246-205-42
Interest Expense011
Unusual Expense
———
Non-Operating Income (Expense)117-66
Net Income Before Taxes-249-22423
Income Taxes-1-27
Consolidated Net Income-249-22216
Net Income From Continuing Operations-249-22216
Net Income-249-22216
EPS (Recurring)-1.98-1.740.15
EPS (Basic, Before Extraordinaries)-1.98-1.740.15
EPS (Diluted)-1.98-1.740.15
EBITDA-233-20937
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio30.7023.72—
Gross Margin100.00100.00100.00
Operating Margin-572.09-379.63-24.85
Net Margin-579.07-411.119.47
Shares Outstanding135122109
Market Capitalization1,3201,281—
Operating Lease Expense
———
Insider Trading Volume
$10.30$9.39$8.47$7.55$6.64● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR